A Double-Blind, Randomised, Placebo-Controlled, Phase 2b Study Evaluating Sorafenib in Combination with Paclitaxel as a First-Line Therapy in Patients with HER2-Negative Advanced Breast Cancer
PT-141 (Bremelanotide) 10MG $51.00 $200+ orders Discount per Quantity Scientific Overview of PT-141 (Bremelanotide) PT-141, also known as Bremelanotide, is a synthetic melanocortin analog derived from Melanotan 2 (MT-2)
Safety Considerations, Eligibility, and When to Seek Provider Guidance Both PlushCare and Ro screen for contraindications (personal or family history of medullary thyroid cancer, MEN 2 syndrome, severe pancreatitis, gallbladder disease)
Patients with a personal or family history of medullary thyroid carcinoma (MTC), or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), should never receive semaglutide or tirzepatide [4]